These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19416767)

  • 1. Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes.
    Wu GW; Kobashigawa JA; Fishbein MC; Patel JK; Kittleson MM; Reed EF; Kiyosaki KK; Ardehali A
    J Heart Lung Transplant; 2009 May; 28(5):417-22. PubMed ID: 19416767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deposition of C4d and C3d in cardiac transplants: a factor in the development of coronary artery vasculopathy.
    Moseley EL; Atkinson C; Sharples LD; Wallwork J; Goddard MJ
    J Heart Lung Transplant; 2010 Apr; 29(4):417-23. PubMed ID: 20188594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C4d immunostaining is an independent predictor of cardiac allograft vasculopathy and death in heart transplant recipients.
    Luk A; Alba AC; Butany J; Tinckam K; Delgado D; Ross HJ
    Transpl Int; 2015 Jul; 28(7):857-63. PubMed ID: 25778989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does asymptomatic recurrent diffuse capillary C4d complement deposition impair cardiac allograft function?
    Frea S; Iacovino C; Botta M; De Filippi I; Mazzucco G; Pidello S; Biolè C; Bergerone S; Boffini M; Praticò Barbato L; Morello M; Rinaldi M; Gaita F
    Clin Transplant; 2016 Oct; 30(10):1314-1323. PubMed ID: 27490635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine C4d immunohistochemistry in cardiac allografts: Long-term outcomes.
    Husain AN; Mirza KM; Fedson SE
    J Heart Lung Transplant; 2017 Dec; 36(12):1329-1335. PubMed ID: 28988608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal evaluation of microvessel density in survivors vs. nonsurvivors of cardiac pathologic antibody-mediated rejection.
    Revelo MP; Miller DV; Stehlik J; Brunisholz K; Drakos S; Gilbert EM; Everitt M; Budge D; Alharethi R; Snow G; Hammond EH; Kfoury AG
    Cardiovasc Pathol; 2012; 21(6):445-54. PubMed ID: 22381397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C4D immunostaining in surveillance endomyocardial biopsies from well-functioning heart allografts.
    Arias LF; Fernández R; Fernández D; Jaramillo JC; Gil M; López García-Asenjo JA
    Transplant Proc; 2010 Jun; 42(5):1793-6. PubMed ID: 20620525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late antibody-mediated rejection after heart transplantation: Mortality, graft function, and fulminant cardiac allograft vasculopathy.
    Coutance G; Ouldamar S; Rouvier P; Saheb S; Suberbielle C; Bréchot N; Hariri S; Lebreton G; Leprince P; Varnous S
    J Heart Lung Transplant; 2015 Aug; 34(8):1050-7. PubMed ID: 25956740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies.
    Behr TM; Feucht HE; Richter K; Reiter C; Spes CH; Pongratz D; Uberfuhr P; Meiser B; Theisen K; Angermann CE
    J Heart Lung Transplant; 1999 Sep; 18(9):904-12. PubMed ID: 10528753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quilty effect areas are frequently associated with endocardial C4d deposition.
    Cano LC; Arteta AA; Fernández R; García-Asenjo JA; Hernández S; Fernández D; Arias LF
    J Heart Lung Transplant; 2008 Jul; 27(7):775-9. PubMed ID: 18582808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C4d analysis in endomyocardial biopsies of heart transplant patients: is there a correlation with hemodynamic data?
    Boffini M; Ricci D; Bonato R; Ribezzo M; Simonato E; Saviolo R; Checco L; Comoglio C; Rinaldi M
    Transplant Proc; 2011 May; 43(4):1168-70. PubMed ID: 21620080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biopsy-diagnosed antibody-mediated rejection based on the proposed International Society for Heart and Lung Transplantation working formulation is associated with adverse cardiovascular outcomes after pediatric heart transplant.
    Everitt MD; Hammond ME; Snow GL; Stehlik J; Revelo MP; Miller DV; Kaza AK; Budge D; Alharethi R; Molina KM; Kfoury AG
    J Heart Lung Transplant; 2012 Jul; 31(7):686-93. PubMed ID: 22551931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma C4d+ Endothelial Microvesicles Increase in Acute Antibody-Mediated Rejection.
    Tower CM; Reyes M; Nelson K; Leca N; Kieran N; Muczynski K; Jefferson JA; Blosser C; Kukla A; Maurer D; Chandler W; Najafian B
    Transplantation; 2017 Sep; 101(9):2235-2243. PubMed ID: 27846156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of morphologic parameters on endomyocardial biopsy to detect sub-clinical antibody-mediated rejection in heart transplantation.
    Fedrigo M; Gambino A; Benazzi E; Poli F; Frigo AC; Tona F; Caforio AL; Castellani C; Toscano G; Feltrin G; Gerosa G; Thiene G; Angelini A
    J Heart Lung Transplant; 2011 Dec; 30(12):1381-8. PubMed ID: 21930398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of circulating donor-specific anti-HLA antibodies and presence of C4d in endomyocardial biopsy with heart allograft outcomes: a single-center, retrospective study.
    Frank R; Molina MR; Wald JW; Goldberg LR; Kamoun M; Lal P
    J Heart Lung Transplant; 2013 Apr; 32(4):410-7. PubMed ID: 23498162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Cellular Rejection and C4d Positivity in Heart Transplantation : A Manifestation of Asymptomatic Antibody-Mediated Rejection?
    Mohamedali B; Pyle J; Bhat G
    Am J Clin Pathol; 2016 Feb; 145(2):238-43. PubMed ID: 26767383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reclassification of C4d-Positive Endomyocardial Biopsy (EMB) According to New International Society for Heart and Lung Transplantation (ISHLT) 2013 Categories for Reporting Pathologic Antibody-Mediated Rejection (pAMR): Preliminary Data from a Polish Single-Center Study.
    Szymańska S; Grajkowska W; Sobieszczańska-Małek M; Zieliński T; Pronicki M
    Ann Transplant; 2015 Jun; 20():351-6. PubMed ID: 26101425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-specific antibodies are associated with micro- and macrovascular coronary disease, restrictive myocardial damage, and poor outcome in heart-transplanted patients.
    Clemmensen TS; Koefoed-Nielsen P; Jensen LA; Poulsen SH; Holm NR; Løgstrup BB; Christiansen EH; Dijkstra J; Valen KPB; Eiskjaer H
    Clin Transplant; 2017 Sep; 31(9):. PubMed ID: 28627046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients.
    Asimacopoulos EP; Garbern JC; Gauvreau K; Blume ED; Daly KP; Singh TP
    Transplantation; 2020 Jan; 104(1):e31-e37. PubMed ID: 31568274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-dependent specificity of immunopathologic (C4d-CD68) and histologic criteria of antibody-mediated rejection for donor-specific antibodies and allograft dysfunction in heart transplantation.
    Yerly P; Rotman S; Nobile A; Aubert V; Tozzi P; Yarol N; Vogt P; Hullin R; Pascual M
    Transplantation; 2015 Mar; 99(3):586-93. PubMed ID: 24983305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.